INMUNE BIO INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
INMUNE BIO INC. (INMB) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $10.50 million as of 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2023-11-01
- 2023-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $10.50M.
- 2023-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $12.70M.
- 2023-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $9.80M.
- 2022-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $13.00M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2023-09-30 | $10.50M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $12.70M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $9.80M 10-Q · filed 2023-05-03 |
| 2022-09-30 | $13.00M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $14.90M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $17.10M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $11.20M 10-K · filed 2023-03-02 |
| 2021-09-30 | $14.60M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $9.90M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $7.30 10-Q · filed 2021-05-05 |
| 2020-12-31 | $13.31M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |